Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
687
datasets available to search
ShareScore release 0.9.0
Dataset results
687 results for “MDS”
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01515527. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of Chemotherapy vs No Chemotherapy Pre-transplant to MDS Undergoing Allo-HSCT
ClinicalTrials.gov study NCT02850822. IPD Sharing: YES. Countries: 1. Publications: 1.
Azacitidine Combined to Epoetin Beta in International Prognostic Scoring System (IPSS) Low-risk and Intermediate-1 Myelodysplastic Syndrome (MDS) Patients, Resistant to Erythropoetin-stimulating Agent
ClinicalTrials.gov study NCT01015352. IPD Sharing: Not stated. Countries: 1. Publications: 1.
G-CSF+Decitabine+BUCY vs BUCY Conditioning Regimen for RAEB-1, REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT
ClinicalTrials.gov study NCT02744742. IPD Sharing: YES. Countries: 1. Publications: 1.
Sterile Inflammation and Molecular Aberrations in MDS
ClinicalTrials.gov study NCT04313231. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood
ClinicalTrials.gov study NCT00662090. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00120653. IPD Sharing: Not stated. Countries: 1. Publications: 1.
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
ClinicalTrials.gov study NCT03113643. IPD Sharing: NO. Countries: 1. Publications: 2.
Decitabine and Arsenic Trioxide for Myelodysplastic Syndrome(MDS)
ClinicalTrials.gov study NCT03377725. IPD Sharing: Not stated. Countries: 1. Publications: 6.
The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q).
ClinicalTrials.gov study NCT01556477. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS
ClinicalTrials.gov study NCT05175508. IPD Sharing: NO. Countries: 1. Publications: 11.
A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00072969. IPD Sharing: Not stated. Countries: 1. Publications: 3.
MDS-CAN: A Prospective National MDS Clinical Database and Local Tissue Bank
ClinicalTrials.gov study NCT02537990. IPD Sharing: YES. Countries: 1. Publications: 2.
Comparing Two Diets in Patients Undergoing HSCT or Remission Induction Chemo for Acute Leukemia and MDS (UF-BMT-LDND-101)
ClinicalTrials.gov study NCT03016130. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Analysis of Risk in MDS Over Time - Comparison of Treated vs Untreated Patients
ClinicalTrials.gov study NCT04676945. IPD Sharing: NO. Countries: 1. Publications: 7.
Observational Study Towards the Impact of Newly Started Treatment in MDS on QoL
ClinicalTrials.gov study NCT04053933. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase I Trial of Vorinostat (MK-0683, SAHA) in Combination With Decitabine in Patients With AML or MDS (MK-0683-055 EXT1)
ClinicalTrials.gov study NCT00479232. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT00472290. IPD Sharing: Not stated. Countries: 0. Publications: 1.
5-azacytidine Treatment Versus 5-azacytidine Followed by Allogeneic Stem Cell Transplantation in Elderly Patients With Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01404741. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Lenalidomide in High-risk MDS and AML With Del(5q) or Monosomy 5
ClinicalTrials.gov study NCT00761449. IPD Sharing: Not stated. Countries: 3. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.